Head of translational immunotherapy research. CIMA (Centro de Investigation Medical Aplicada), Navarra. (SP)
Cancer Research Editorial Board Member.
Brenus’ manufacturing process overpasses the lack of immunogenicity & educates the immune system with visible and multi-specific targets
Selection criteria of starting material (Allogeneic tumor cell lines)
Brenus’ manufacturing process overpasses the lack of antigenicity & educates the immune system with a broad & higher quality range of tumor antigens